Gamma-glutamyl transpeptidase level associated with metabolic syndrome and proinflammatory parameters in the young Roma population in eastern Slovakia: a population-based study

Elevated gamma-glutamyl transpeptidase (GGT) is present approximately in half of all patients with non-alcoholic fatty liver disease (NAFLD). NAFLD is the liver manifestation of metabolic syndrome (MS). This study aimed to explore the relationship between GGT and MS or proinflammatory parameters. Da...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Central European journal of public health 2014-03, Vol.22 Suppl (Supplement), p.S43-S50
Hauptverfasser: Jarcuska, Peter, Janicko, Martin, Drazilová, Sylvia, Senajová, Gabriela, Veselíny, Eduard, Fedacko, Ján, Siegfried, Leonard, Kristian, Pavol, Tkác, Jr, Michal, Pella, Daniel, Mareková, Mária, Gecková, Andrea Madarasová, Jarcuska, Pavol
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page S50
container_issue Supplement
container_start_page S43
container_title Central European journal of public health
container_volume 22 Suppl
creator Jarcuska, Peter
Janicko, Martin
Drazilová, Sylvia
Senajová, Gabriela
Veselíny, Eduard
Fedacko, Ján
Siegfried, Leonard
Kristian, Pavol
Tkác, Jr, Michal
Pella, Daniel
Mareková, Mária
Gecková, Andrea Madarasová
Jarcuska, Pavol
description Elevated gamma-glutamyl transpeptidase (GGT) is present approximately in half of all patients with non-alcoholic fatty liver disease (NAFLD). NAFLD is the liver manifestation of metabolic syndrome (MS). This study aimed to explore the relationship between GGT and MS or proinflammatory parameters. Data from the cross-sectional HepaMeta study conducted in Slovakia in 2011 among Roma living in rural communities were used. Participants (n = 446) were divided into 2 groups; those with elevated GGT and those with normal GGT levels. MS was diagnosed according to the International Diabetes Federation criteria; presence of central obesity and low density lipoproteins (LDL) or high density lipoproteins (HDL), high triglycerides, hypertension, glucose intolerance or type 2 diabetes. Participants were tested for the presence of MS and its components, and biochemical tests for lipid levels (total cholesterol, HDL, LDL, TG) and inflammatory parameters (high sensitivity C-reactive protein--hs-CRP and ferritin) were performed. Of 446 Roma participants, only 29 (6.5%) had GGT levels above the normal value. After exclusion of patients with viral hepatitis and alcohol abuse, patients with elevated GGT suffered from MS more often (p < 0.001), and patients with more MS components had a higher risk of elevated GGT. We found a significant association between GGT and the individual MS components, except HDL (waist circumference > or = 94 cm in men or 80 cm in women: p < 0.01; BMI > 30: p < 0.001; fasting glucose > or = 5.6 mmol/l: p < 0.001; arterial hypertension: p < 0.05, and TAG > or = 1.7 mmol/l: p < 0.001). Patients with elevated GGT levels had also significantly higher hs-CRP (hs-CRP > 2 mg/l: p < 0.001; hs-CRP > 3 mg/l: p < 0.001) and ferritin (ferritin > 300 mg/l: p < 0.01) levels. Patients with MS have more significantly elevated levels of GGT. There is a significant association of GGT with individual MS components, except HDL and inflammatory parameters (hs-CRP, ferritin).
doi_str_mv 10.21101/cejph.a3901
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1528339059</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1528339059</sourcerecordid><originalsourceid>FETCH-LOGICAL-c329t-2ffd579699393d4473710b882d6b1b20de5f5657971b09c08d9f1a1e2a356bb73</originalsourceid><addsrcrecordid>eNpNkctu1jAQRiMEoqWwY428ZEFaX5I4Zoeq0laqVInLOprEk_4uvgTbKcpb9RFx_xbU1Yw0R59m5lTVe0aPOWOUnUx4u-yOQSjKXlSHrKeiZrTpX5aeM1pLKfuD6k1Kt5S2LRfd6-qAN30jO9YcVvfn4BzUN3bN4DZLcgSfFlyy0ZCQWLxDSyClMBnIqMkfk3fEYYYxWDORtHkdg0MCXpMlBuNn-xCYQ9zIAhEKijER40neIdnC6m_It-CALGFZLWQT_MMQIRXOk-823MEvA5_Jc6Ieyy6apLzq7W31agab8N1TPap-fj37cXpRX12fX55-uaonwVWu-TzrVqpOKaGEbhopJKNj33PdjWzkVGM7t10hJBupmmiv1cyAIQfRduMoxVH18TG3XPV7xZQHZ9KE1oLHsKaBtbwX5eetKuinR3SKIaWI87BE4yBuA6PD3tGwdzTsHRX8w1PyOjrU_-F_UsRfEJGStg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1528339059</pqid></control><display><type>article</type><title>Gamma-glutamyl transpeptidase level associated with metabolic syndrome and proinflammatory parameters in the young Roma population in eastern Slovakia: a population-based study</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Jarcuska, Peter ; Janicko, Martin ; Drazilová, Sylvia ; Senajová, Gabriela ; Veselíny, Eduard ; Fedacko, Ján ; Siegfried, Leonard ; Kristian, Pavol ; Tkác, Jr, Michal ; Pella, Daniel ; Mareková, Mária ; Gecková, Andrea Madarasová ; Jarcuska, Pavol</creator><creatorcontrib>Jarcuska, Peter ; Janicko, Martin ; Drazilová, Sylvia ; Senajová, Gabriela ; Veselíny, Eduard ; Fedacko, Ján ; Siegfried, Leonard ; Kristian, Pavol ; Tkác, Jr, Michal ; Pella, Daniel ; Mareková, Mária ; Gecková, Andrea Madarasová ; Jarcuska, Pavol ; HepaMeta Team</creatorcontrib><description><![CDATA[Elevated gamma-glutamyl transpeptidase (GGT) is present approximately in half of all patients with non-alcoholic fatty liver disease (NAFLD). NAFLD is the liver manifestation of metabolic syndrome (MS). This study aimed to explore the relationship between GGT and MS or proinflammatory parameters. Data from the cross-sectional HepaMeta study conducted in Slovakia in 2011 among Roma living in rural communities were used. Participants (n = 446) were divided into 2 groups; those with elevated GGT and those with normal GGT levels. MS was diagnosed according to the International Diabetes Federation criteria; presence of central obesity and low density lipoproteins (LDL) or high density lipoproteins (HDL), high triglycerides, hypertension, glucose intolerance or type 2 diabetes. Participants were tested for the presence of MS and its components, and biochemical tests for lipid levels (total cholesterol, HDL, LDL, TG) and inflammatory parameters (high sensitivity C-reactive protein--hs-CRP and ferritin) were performed. Of 446 Roma participants, only 29 (6.5%) had GGT levels above the normal value. After exclusion of patients with viral hepatitis and alcohol abuse, patients with elevated GGT suffered from MS more often (p < 0.001), and patients with more MS components had a higher risk of elevated GGT. We found a significant association between GGT and the individual MS components, except HDL (waist circumference > or = 94 cm in men or 80 cm in women: p < 0.01; BMI > 30: p < 0.001; fasting glucose > or = 5.6 mmol/l: p < 0.001; arterial hypertension: p < 0.05, and TAG > or = 1.7 mmol/l: p < 0.001). Patients with elevated GGT levels had also significantly higher hs-CRP (hs-CRP > 2 mg/l: p < 0.001; hs-CRP > 3 mg/l: p < 0.001) and ferritin (ferritin > 300 mg/l: p < 0.01) levels. Patients with MS have more significantly elevated levels of GGT. There is a significant association of GGT with individual MS components, except HDL and inflammatory parameters (hs-CRP, ferritin).]]></description><identifier>ISSN: 1210-7778</identifier><identifier>EISSN: 1803-1048</identifier><identifier>DOI: 10.21101/cejph.a3901</identifier><identifier>PMID: 24847614</identifier><language>eng</language><publisher>Czech Republic</publisher><subject>Adolescent ; Adult ; C-Reactive Protein ; Comorbidity ; Cross-Sectional Studies ; Diet - ethnology ; Diet - methods ; Diet - statistics &amp; numerical data ; Fatty Liver - blood ; Fatty Liver - ethnology ; Female ; Ferritins - blood ; gamma-Glutamyltransferase - blood ; Health Surveys - methods ; Health Surveys - statistics &amp; numerical data ; Humans ; Inflammation - blood ; Inflammation - epidemiology ; Inflammation - ethnology ; Lipids - blood ; Male ; Metabolic Syndrome - enzymology ; Metabolic Syndrome - ethnology ; Middle Aged ; Motor Activity - physiology ; Non-alcoholic Fatty Liver Disease ; Risk Factors ; Roma - ethnology ; Roma - statistics &amp; numerical data ; Rural Population - statistics &amp; numerical data ; Slovakia - epidemiology ; Socioeconomic Factors ; Surveys and Questionnaires ; Young Adult</subject><ispartof>Central European journal of public health, 2014-03, Vol.22 Suppl (Supplement), p.S43-S50</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c329t-2ffd579699393d4473710b882d6b1b20de5f5657971b09c08d9f1a1e2a356bb73</citedby><cites>FETCH-LOGICAL-c329t-2ffd579699393d4473710b882d6b1b20de5f5657971b09c08d9f1a1e2a356bb73</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27928,27929</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24847614$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jarcuska, Peter</creatorcontrib><creatorcontrib>Janicko, Martin</creatorcontrib><creatorcontrib>Drazilová, Sylvia</creatorcontrib><creatorcontrib>Senajová, Gabriela</creatorcontrib><creatorcontrib>Veselíny, Eduard</creatorcontrib><creatorcontrib>Fedacko, Ján</creatorcontrib><creatorcontrib>Siegfried, Leonard</creatorcontrib><creatorcontrib>Kristian, Pavol</creatorcontrib><creatorcontrib>Tkác, Jr, Michal</creatorcontrib><creatorcontrib>Pella, Daniel</creatorcontrib><creatorcontrib>Mareková, Mária</creatorcontrib><creatorcontrib>Gecková, Andrea Madarasová</creatorcontrib><creatorcontrib>Jarcuska, Pavol</creatorcontrib><creatorcontrib>HepaMeta Team</creatorcontrib><title>Gamma-glutamyl transpeptidase level associated with metabolic syndrome and proinflammatory parameters in the young Roma population in eastern Slovakia: a population-based study</title><title>Central European journal of public health</title><addtitle>Cent Eur J Public Health</addtitle><description><![CDATA[Elevated gamma-glutamyl transpeptidase (GGT) is present approximately in half of all patients with non-alcoholic fatty liver disease (NAFLD). NAFLD is the liver manifestation of metabolic syndrome (MS). This study aimed to explore the relationship between GGT and MS or proinflammatory parameters. Data from the cross-sectional HepaMeta study conducted in Slovakia in 2011 among Roma living in rural communities were used. Participants (n = 446) were divided into 2 groups; those with elevated GGT and those with normal GGT levels. MS was diagnosed according to the International Diabetes Federation criteria; presence of central obesity and low density lipoproteins (LDL) or high density lipoproteins (HDL), high triglycerides, hypertension, glucose intolerance or type 2 diabetes. Participants were tested for the presence of MS and its components, and biochemical tests for lipid levels (total cholesterol, HDL, LDL, TG) and inflammatory parameters (high sensitivity C-reactive protein--hs-CRP and ferritin) were performed. Of 446 Roma participants, only 29 (6.5%) had GGT levels above the normal value. After exclusion of patients with viral hepatitis and alcohol abuse, patients with elevated GGT suffered from MS more often (p < 0.001), and patients with more MS components had a higher risk of elevated GGT. We found a significant association between GGT and the individual MS components, except HDL (waist circumference > or = 94 cm in men or 80 cm in women: p < 0.01; BMI > 30: p < 0.001; fasting glucose > or = 5.6 mmol/l: p < 0.001; arterial hypertension: p < 0.05, and TAG > or = 1.7 mmol/l: p < 0.001). Patients with elevated GGT levels had also significantly higher hs-CRP (hs-CRP > 2 mg/l: p < 0.001; hs-CRP > 3 mg/l: p < 0.001) and ferritin (ferritin > 300 mg/l: p < 0.01) levels. Patients with MS have more significantly elevated levels of GGT. There is a significant association of GGT with individual MS components, except HDL and inflammatory parameters (hs-CRP, ferritin).]]></description><subject>Adolescent</subject><subject>Adult</subject><subject>C-Reactive Protein</subject><subject>Comorbidity</subject><subject>Cross-Sectional Studies</subject><subject>Diet - ethnology</subject><subject>Diet - methods</subject><subject>Diet - statistics &amp; numerical data</subject><subject>Fatty Liver - blood</subject><subject>Fatty Liver - ethnology</subject><subject>Female</subject><subject>Ferritins - blood</subject><subject>gamma-Glutamyltransferase - blood</subject><subject>Health Surveys - methods</subject><subject>Health Surveys - statistics &amp; numerical data</subject><subject>Humans</subject><subject>Inflammation - blood</subject><subject>Inflammation - epidemiology</subject><subject>Inflammation - ethnology</subject><subject>Lipids - blood</subject><subject>Male</subject><subject>Metabolic Syndrome - enzymology</subject><subject>Metabolic Syndrome - ethnology</subject><subject>Middle Aged</subject><subject>Motor Activity - physiology</subject><subject>Non-alcoholic Fatty Liver Disease</subject><subject>Risk Factors</subject><subject>Roma - ethnology</subject><subject>Roma - statistics &amp; numerical data</subject><subject>Rural Population - statistics &amp; numerical data</subject><subject>Slovakia - epidemiology</subject><subject>Socioeconomic Factors</subject><subject>Surveys and Questionnaires</subject><subject>Young Adult</subject><issn>1210-7778</issn><issn>1803-1048</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkctu1jAQRiMEoqWwY428ZEFaX5I4Zoeq0laqVInLOprEk_4uvgTbKcpb9RFx_xbU1Yw0R59m5lTVe0aPOWOUnUx4u-yOQSjKXlSHrKeiZrTpX5aeM1pLKfuD6k1Kt5S2LRfd6-qAN30jO9YcVvfn4BzUN3bN4DZLcgSfFlyy0ZCQWLxDSyClMBnIqMkfk3fEYYYxWDORtHkdg0MCXpMlBuNn-xCYQ9zIAhEKijER40neIdnC6m_It-CALGFZLWQT_MMQIRXOk-823MEvA5_Jc6Ieyy6apLzq7W31agab8N1TPap-fj37cXpRX12fX55-uaonwVWu-TzrVqpOKaGEbhopJKNj33PdjWzkVGM7t10hJBupmmiv1cyAIQfRduMoxVH18TG3XPV7xZQHZ9KE1oLHsKaBtbwX5eetKuinR3SKIaWI87BE4yBuA6PD3tGwdzTsHRX8w1PyOjrU_-F_UsRfEJGStg</recordid><startdate>20140301</startdate><enddate>20140301</enddate><creator>Jarcuska, Peter</creator><creator>Janicko, Martin</creator><creator>Drazilová, Sylvia</creator><creator>Senajová, Gabriela</creator><creator>Veselíny, Eduard</creator><creator>Fedacko, Ján</creator><creator>Siegfried, Leonard</creator><creator>Kristian, Pavol</creator><creator>Tkác, Jr, Michal</creator><creator>Pella, Daniel</creator><creator>Mareková, Mária</creator><creator>Gecková, Andrea Madarasová</creator><creator>Jarcuska, Pavol</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20140301</creationdate><title>Gamma-glutamyl transpeptidase level associated with metabolic syndrome and proinflammatory parameters in the young Roma population in eastern Slovakia: a population-based study</title><author>Jarcuska, Peter ; Janicko, Martin ; Drazilová, Sylvia ; Senajová, Gabriela ; Veselíny, Eduard ; Fedacko, Ján ; Siegfried, Leonard ; Kristian, Pavol ; Tkác, Jr, Michal ; Pella, Daniel ; Mareková, Mária ; Gecková, Andrea Madarasová ; Jarcuska, Pavol</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c329t-2ffd579699393d4473710b882d6b1b20de5f5657971b09c08d9f1a1e2a356bb73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>C-Reactive Protein</topic><topic>Comorbidity</topic><topic>Cross-Sectional Studies</topic><topic>Diet - ethnology</topic><topic>Diet - methods</topic><topic>Diet - statistics &amp; numerical data</topic><topic>Fatty Liver - blood</topic><topic>Fatty Liver - ethnology</topic><topic>Female</topic><topic>Ferritins - blood</topic><topic>gamma-Glutamyltransferase - blood</topic><topic>Health Surveys - methods</topic><topic>Health Surveys - statistics &amp; numerical data</topic><topic>Humans</topic><topic>Inflammation - blood</topic><topic>Inflammation - epidemiology</topic><topic>Inflammation - ethnology</topic><topic>Lipids - blood</topic><topic>Male</topic><topic>Metabolic Syndrome - enzymology</topic><topic>Metabolic Syndrome - ethnology</topic><topic>Middle Aged</topic><topic>Motor Activity - physiology</topic><topic>Non-alcoholic Fatty Liver Disease</topic><topic>Risk Factors</topic><topic>Roma - ethnology</topic><topic>Roma - statistics &amp; numerical data</topic><topic>Rural Population - statistics &amp; numerical data</topic><topic>Slovakia - epidemiology</topic><topic>Socioeconomic Factors</topic><topic>Surveys and Questionnaires</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jarcuska, Peter</creatorcontrib><creatorcontrib>Janicko, Martin</creatorcontrib><creatorcontrib>Drazilová, Sylvia</creatorcontrib><creatorcontrib>Senajová, Gabriela</creatorcontrib><creatorcontrib>Veselíny, Eduard</creatorcontrib><creatorcontrib>Fedacko, Ján</creatorcontrib><creatorcontrib>Siegfried, Leonard</creatorcontrib><creatorcontrib>Kristian, Pavol</creatorcontrib><creatorcontrib>Tkác, Jr, Michal</creatorcontrib><creatorcontrib>Pella, Daniel</creatorcontrib><creatorcontrib>Mareková, Mária</creatorcontrib><creatorcontrib>Gecková, Andrea Madarasová</creatorcontrib><creatorcontrib>Jarcuska, Pavol</creatorcontrib><creatorcontrib>HepaMeta Team</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Central European journal of public health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jarcuska, Peter</au><au>Janicko, Martin</au><au>Drazilová, Sylvia</au><au>Senajová, Gabriela</au><au>Veselíny, Eduard</au><au>Fedacko, Ján</au><au>Siegfried, Leonard</au><au>Kristian, Pavol</au><au>Tkác, Jr, Michal</au><au>Pella, Daniel</au><au>Mareková, Mária</au><au>Gecková, Andrea Madarasová</au><au>Jarcuska, Pavol</au><aucorp>HepaMeta Team</aucorp><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gamma-glutamyl transpeptidase level associated with metabolic syndrome and proinflammatory parameters in the young Roma population in eastern Slovakia: a population-based study</atitle><jtitle>Central European journal of public health</jtitle><addtitle>Cent Eur J Public Health</addtitle><date>2014-03-01</date><risdate>2014</risdate><volume>22 Suppl</volume><issue>Supplement</issue><spage>S43</spage><epage>S50</epage><pages>S43-S50</pages><issn>1210-7778</issn><eissn>1803-1048</eissn><abstract><![CDATA[Elevated gamma-glutamyl transpeptidase (GGT) is present approximately in half of all patients with non-alcoholic fatty liver disease (NAFLD). NAFLD is the liver manifestation of metabolic syndrome (MS). This study aimed to explore the relationship between GGT and MS or proinflammatory parameters. Data from the cross-sectional HepaMeta study conducted in Slovakia in 2011 among Roma living in rural communities were used. Participants (n = 446) were divided into 2 groups; those with elevated GGT and those with normal GGT levels. MS was diagnosed according to the International Diabetes Federation criteria; presence of central obesity and low density lipoproteins (LDL) or high density lipoproteins (HDL), high triglycerides, hypertension, glucose intolerance or type 2 diabetes. Participants were tested for the presence of MS and its components, and biochemical tests for lipid levels (total cholesterol, HDL, LDL, TG) and inflammatory parameters (high sensitivity C-reactive protein--hs-CRP and ferritin) were performed. Of 446 Roma participants, only 29 (6.5%) had GGT levels above the normal value. After exclusion of patients with viral hepatitis and alcohol abuse, patients with elevated GGT suffered from MS more often (p < 0.001), and patients with more MS components had a higher risk of elevated GGT. We found a significant association between GGT and the individual MS components, except HDL (waist circumference > or = 94 cm in men or 80 cm in women: p < 0.01; BMI > 30: p < 0.001; fasting glucose > or = 5.6 mmol/l: p < 0.001; arterial hypertension: p < 0.05, and TAG > or = 1.7 mmol/l: p < 0.001). Patients with elevated GGT levels had also significantly higher hs-CRP (hs-CRP > 2 mg/l: p < 0.001; hs-CRP > 3 mg/l: p < 0.001) and ferritin (ferritin > 300 mg/l: p < 0.01) levels. Patients with MS have more significantly elevated levels of GGT. There is a significant association of GGT with individual MS components, except HDL and inflammatory parameters (hs-CRP, ferritin).]]></abstract><cop>Czech Republic</cop><pmid>24847614</pmid><doi>10.21101/cejph.a3901</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1210-7778
ispartof Central European journal of public health, 2014-03, Vol.22 Suppl (Supplement), p.S43-S50
issn 1210-7778
1803-1048
language eng
recordid cdi_proquest_miscellaneous_1528339059
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Adolescent
Adult
C-Reactive Protein
Comorbidity
Cross-Sectional Studies
Diet - ethnology
Diet - methods
Diet - statistics & numerical data
Fatty Liver - blood
Fatty Liver - ethnology
Female
Ferritins - blood
gamma-Glutamyltransferase - blood
Health Surveys - methods
Health Surveys - statistics & numerical data
Humans
Inflammation - blood
Inflammation - epidemiology
Inflammation - ethnology
Lipids - blood
Male
Metabolic Syndrome - enzymology
Metabolic Syndrome - ethnology
Middle Aged
Motor Activity - physiology
Non-alcoholic Fatty Liver Disease
Risk Factors
Roma - ethnology
Roma - statistics & numerical data
Rural Population - statistics & numerical data
Slovakia - epidemiology
Socioeconomic Factors
Surveys and Questionnaires
Young Adult
title Gamma-glutamyl transpeptidase level associated with metabolic syndrome and proinflammatory parameters in the young Roma population in eastern Slovakia: a population-based study
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T05%3A08%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gamma-glutamyl%20transpeptidase%20level%20associated%20with%20metabolic%20syndrome%20and%20proinflammatory%20parameters%20in%20the%20young%20Roma%20population%20in%20eastern%20Slovakia:%20a%20population-based%20study&rft.jtitle=Central%20European%20journal%20of%20public%20health&rft.au=Jarcuska,%20Peter&rft.aucorp=HepaMeta%20Team&rft.date=2014-03-01&rft.volume=22%20Suppl&rft.issue=Supplement&rft.spage=S43&rft.epage=S50&rft.pages=S43-S50&rft.issn=1210-7778&rft.eissn=1803-1048&rft_id=info:doi/10.21101/cejph.a3901&rft_dat=%3Cproquest_cross%3E1528339059%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1528339059&rft_id=info:pmid/24847614&rfr_iscdi=true